doi: 10.3389/fphys.2026.1826699 Received 09 March 2026 Revised 02 April 2026 Accepted 09 April 2026 Published 28 April 2026 Volume 17 - 2026 Edited by Satoko Shinjo, University of Padua, Italy Reviewed by Alejandra Tomas, Imperial College London, United Kingdom Emily Walker, Wayne State University, United States Updates Copyright 2026 Cruz, Puebla-Huerta, Troncoso, Silva-Pavez, Hidalgo-Fadic and Ahumada-Castro
King, M., Ganley, I
Exendin-4 modifies adipogenesis of human adipose-derived stromal cells isolated from omentum through multiple mechanisms
Patients were considered as receiving the study drug class for the period during which prescriptions for the same drug class were refilled before the estimated end date of the most recent prescription, including a grace period of 90 days to account for irregular drug use
2 FDA Guidance for Industry: Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act at 8
